Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
Young Suk Kim, Chang Geol Lee, Kyung Hwan Kim, Taehyung Kim, Joohwan Lee, Yona Cho, Woong Sub Koom
Radiat Oncol J. 2012;30(4):182-188. Published online 2012 Dec 31 DOI: https://doi.org/10.3857/roj.2012.30.4.182
|
Citations to this article as recorded by
Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry Trial
Alexandra Hotca, Kunal K. Sindhu, Eric J. Lehrer, William F. Hartsell, Carlos Vargas, Henry K. Tsai, John H. Chang, Smith Apisarnthanarax, Romaine C. Nichols, Arpit M. Chhabra, Shaakir Hasan, Robert H. Press, Stanislav Lazarev, Carla Hajj, Rafi Kabarriti,
Advances in Radiation Oncology.2024; 9(5): 101459. CrossRef Treatment Strategies for Locoregional Recurrence in Esophageal Squamous-Cell Carcinoma: An Updated Review
Atsushi Mitamura, Shingo Tsujinaka, Toru Nakano, Kentaro Sawada, Chikashi Shibata
Cancers.2024; 16(14): 2539. CrossRef Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation
Zhuocheng Xin, Qi Liu, Dashan Ai, Ke Chen, Elene Mariamidze, Mostafa Aziz Sumon, Bharti Devnani, Rille Pihlak, Hongcheng Zhu, Kuaile Zhao
Current Treatment Options in Oncology.2023; 24(11): 1568. CrossRef Re-irradiation for intra-thoracic tumours and extra-thoracic breast cancer: dose accumulation, evaluation of efficacy and toxicity based on a literature review
Dorota Gabrys, Roland Kulik, Agnieszka Namysł-Kaletka
The British Journal of Radiology.2022;[Epub] CrossRef Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site
Xinran Wang, Bing Hu, Jinhu Chen, Feihong Xie, Dan Han, Qian Zhao, Hongfu Sun, Chengrui Fu, Chengxin Liu, Zhongtang Wang, Haiqun Lin, Wei Huang
BMC Cancer.2022;[Epub] CrossRef Efficacy and safety of re-irradiation for locoregional esophageal squamous cell carcinoma recurrence after radiotherapy: a systematic review and meta-analysis
Kuntian Lan, Jiaohong Chen
Radiation Oncology.2022;[Epub] CrossRef A Phase II Study of Apatinib in Patients with Chemotherapy-Refractory Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11)
Li Chu, Yun Chen, Qi Liu, Fei Liang, Shengping Wang, Quan Liu, Hui Yu, Xianghua Wu, Junhua Zhang, Jiaying Deng, Dashan Ai, Zhengfei Zhu, Yongzhan Nie, Kuaile Zhao
The Oncologist.2021; 26(6): e925. CrossRef Definitive chemoradiotherapy for clinical T4b esophageal cancer – Treatment outcomes, failure patterns, and prognostic factors
Tzu-Ting Huang, Shau-Hsuan Li, Yen-Hao Chen, Hung-I Lu, Chien-Ming Lo, Fu-Min Fang, Shang-Yu Chou, Yi-Chun Chiu, Yeh-Pin Chou, Yu-Ming Wang
Radiotherapy and Oncology.2021; 157: 56. CrossRef Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer
J. de Vos-Geelen, S.M.E. Geurts, G.A.P. Nieuwenhuijzen, F.E.M. Voncken, J.A. Bogers, P.M. Braam, C.T. Muijs, M.A. de Jong, N. Kasperts, T. Rozema, G.J. Blom, S.A.W. Bouwense, L.B.J. Valkenburg-van Iersel, P.M. Jeene, F.J.P. Hoebers, V.C.G. Tjan-Heijnen
European Journal of Surgical Oncology.2021; 47(8): 2016. CrossRef Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma
Koichi Yagi, Tetsuro Toriumi, Susumu Aikou, Hiroharu Yamashita, Yasuyuki Seto
Annals of Gastroenterological Surgery.2021; 5(4): 436. CrossRef Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma
Tzu-Hui Pao, Ying-Yuan Chen, Wei-Lun Chang, Jeffrey Shu-Ming Chang, Nai-Jung Chiang, Chia-Ying Lin, Wu-Wei Lai, Yau-Lin Tseng, Yi-Ting Yen, Ta-Jung Chung, Forn-Chia Lin, Wen-Chi Chou
PLOS ONE.2021; 16(5): e0251811. CrossRef A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy
Xun Wu, Xingsheng Hu, Junru Chen, Lang He
Radiation Oncology.2021;[Epub] CrossRef Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees
Michael D. Chuong, Christopher L. Hallemeier, Heng Li, Xiaorong Ronald Zhu, Xiaodong Zhang, Erik J. Tryggestad, Jen Yu, Ming Yang, J. Isabelle Choi, Minglei Kang, Wei Liu, Antje Knopf, Arturs Meijers, Jason K. Molitoris, Smith Apisarnthanarax, Huan Giap,
Frontiers in Oncology.2021;[Epub] CrossRef Assessing Outcomes of Patients Treated With Re-Irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction
Cristina M. DeCesaris, Rachel McCarroll, Mark V. Mishra, Erica Glass, Bruce D. Greenwald, Shamus Carr, Whitney Burrows, Ranee Mehra, William F. Regine, Charles B. Simone, J. Isabelle Choi, Jason K. Molitoris
Journal of Thoracic Oncology.2020; 15(6): 1054. CrossRef Definitive re‑irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance status
Daniel Kim, Sana Raoof, Nayan Lamba, Grace Lee, Danielle Bitterman, Amandeep Mahal, Nina Sanford, Miranda Lam, Harvey Mamon
Molecular and Clinical Oncology.2020; 13(1): 27. CrossRef Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis
Kaikai Zhao, Youjiao Si, Liangchao Sun, Xiangjiao Meng, Jinming Yu
Radiation Oncology.2020;[Epub] CrossRef Risk Factors for Esophageal Fistula in Esophageal Cancer Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis
Chao Zhu, Songping Wang, Yunhong You, Keke Nie, Youxin Ji
Oncology Research and Treatment.2020; 43(1-2): 34. CrossRef Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy
Jie Li, Zhenhua Zhao, Guobo Du, Tangzhi Dai, Xuhai Zhen, Hongwei Cai, Dongbiao Liao, Miao Xiang, Yixue Wen, Lidan Geng, Xiyue Yang, Gang Feng, Yu Zhang, Jie Bai, Lei Liu, Xiaobo Du
Medicine.2019; 98(26): e16176. CrossRef Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy
Xiujuan Xu, Zhongming Wang, Shunian Jiang, Yuping Shang, Yan Wu
Radiation Oncology.2019;[Epub] CrossRef Clinical application of oral meglumine diatrizoate esophagogram in screening esophageal fistula during radiotherapy for esophageal cancer
Lidan Geng, Rong Wu, He Hu, Yu Zhao, Lingli Fan, Zhenhua Zhao, Dongbiao Liao, Musheng Li, Miao Xiang, Ying Ma, Xiaobo Du
Medicine.2018; 97(18): e0668. CrossRef The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer
Paul M. Jeene, Hanneke W.M. van Laarhoven, Maarten C.C.M. Hulshof
Best Practice & Research Clinical Gastroenterology.2018; 36-37: 53. CrossRef Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
Keiichi Jingu, Yuzuru Niibe, Hideomi Yamashita, Kuniaki Katsui, Toshihiko Matsumoto, Tomohiro Nishina, Atsuro Terahara
Radiation Oncology.2017;[Epub] CrossRef Re-irradiation of locoregional esophageal cancer recurrence following definitive chemoradiotherapy: A report of 6 cases
Atsuto Katano, Hideomi Yamashita, Keiichi Nakagawa
Molecular and Clinical Oncology.2017; 7(4): 681. CrossRef Stereotactic radiotherapy in the treatment of local recurrences of esophageal cancer
Marcel Matzenauer, David Vrána, Zuzana Vlachová, Rene Aujesky, Radek Vrba, Cestmir Neoral, Bohuslav Melichar
Oncology Letters.2017; 13(3): 1807. CrossRef High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer
Nils H. Nicolay, Johanna Rademacher, Jan Oelmann-Avendano, Jürgen Debus, Peter E. Huber, Katja Lindel
Strahlentherapie und Onkologie.2016; 192(7): 458. CrossRef An Unusual Course of Metastatic Gastroesophageal Cancer
William H. Smith, Sofya Pintova, Christopher J. DiMaio, Panagiotis Manolas, Dong-Seok Lee, Spiros P. Hiotis, Maria Kartsonis, Randall F. Holcombe, Kavita V. Dharmarajan
Case Reports in Oncological Medicine.2015; 2015: 1. CrossRef The Efficacy and Safety of Re-Irradiation for 18 Patients with Malignant Tumor
耕 宋
Asian Case Reports in Oncology.2013; 02(04): 17. CrossRef
|